-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>
Through this license agreement, Dow Biotech can use Lonza's XS ® Pichia expression system to develop a scalable, stable and reliable expression process
Peter Droc , Head of Lonza’s Global Licensing and Preparation Services Department , said: “The new generation of therapy requires the use of new expression systems
Dr.
For more detailed information about XS Technologies®, please visit: https://pharma.